Showing results (901-910 of 1,006) with videos related to

Sort By:
Pageof 101
Journal of the American Academy of Dermatology|June 21, 2021
Late-onset adverse events of anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohortClémentine Carlet, Stéphane Dalle, Marie-Thérèse Leccia, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2023
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomasE Toulemonde, S Chevret, M Battistella, et al.
Nature Communications|August 22, 2023
Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapyElaine Lai-Han Leung, Run-Ze Li, Xing-Xing Fan, et al.
Journal of Thrombosis and Thrombolysis|August 4, 2021
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarctionJohny Nicolas, Frans Beerkens, Davide Cao, et al.
International Journal of Molecular Sciences|August 26, 2022
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker DiscoveryAntonio Paolo Beltrami, Maria De Martino, Emiliano Dalla, et al.
European Journal of Clinical Investigation|February 13, 2025
Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysisMarta Perachino, Eva Blondeaux, Chiara Molinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 29, 2024
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PETA Gennari, E Brain, A De Censi, et al.
Histopathology|October 13, 2023
Detection of wildtype Merkel cell polyomavirus genomic sequence and VP1 transcription in a subset of Merkel cell carcinomaThibault Kervarrec, Silke Appenzeller, Anne Tallet, et al.
Pageof 101